Clinical and translational advances in ovarian cancer therapy

PA Konstantinopoulos, UA Matulonis - Nature Cancer, 2023 - nature.com
Ovarian cancer is an aggressive disease that is frequently detected at advanced stages and
is initially very responsive to platinum-based chemotherapy. However, the majority of …

[HTML][HTML] What is new on ovarian carcinoma: integrated morphologic and molecular analysis following the new 2020 World Health Organization classification of female …

A De Leo, D Santini, C Ceccarelli, G Santandrea… - Diagnostics, 2021 - mdpi.com
Ovarian carcinomas represent a heterogeneous group of neoplasms consisting of separate
entities with distinct risk factors, precursor lesions, pathogenesis, patterns of spread …

Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup

I Vergote, A Gonzalez-Martin, D Lorusso… - The Lancet …, 2022 - thelancet.com
Summary The Gynecologic Cancer InterGroup (GCIG) sixth Ovarian Cancer Conference on
Clinical Research was held virtually in October, 2021, following published consensus …

[HTML][HTML] Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes

BM Barnes, L Nelson, A Tighe, GJ Burghel, IH Lin… - Genome Medicine, 2021 - Springer
Background Epithelial ovarian cancer (OC) is a heterogenous disease consisting of five
major histologically distinct subtypes: high-grade serous (HGSOC), low-grade serous …

[HTML][HTML] The evolution of ovarian carcinoma subclassification

M Köbel, EY Kang - Cancers, 2022 - mdpi.com
Simple Summary Historically, cancers presenting with their main tumor mass in the ovary
have been classified as ovarian carcinomas (a concise term for epithelial ovarian cancer) …

[HTML][HTML] Molecular characteristics and clinical behaviour of epithelial ovarian cancers

RL Hollis - Cancer letters, 2023 - Elsevier
Ovarian carcinoma (OC) is an umbrella term for multiple distinct diseases (histotypes), each
with their own developmental origins, clinical behaviour and molecular profile. Accordingly …

[HTML][HTML] Biology-driven therapy advances in high-grade serous ovarian cancer

Y Wang, AJ Duval, M Adli, D Matei - The Journal of Clinical …, 2024 - Am Soc Clin Investig
Following a period of slow progress, the completion of genome sequencing and the
paradigm shift relative to the cell of origin for high grade serous ovarian cancer (HGSOC) led …

[HTML][HTML] Endometriosis-associated ovarian carcinomas: how PI3K/AKT/mTOR pathway affects their pathogenesis

TS Driva, C Schatz, J Haybaeck - Biomolecules, 2023 - mdpi.com
Ovarian clear cell (OCCC) and endometrioid (EnOC) carcinomas are often subsumed under
the umbrella term “endometriosis-associated ovarian cancer”(EAOC), since they frequently …

[HTML][HTML] Three-dimensional modelling of ovarian cancer: From cell lines to organoids for discovery and personalized medicine

C Yee, KA Dickson, MN Muntasir, Y Ma… - … in Bioengineering and …, 2022 - frontiersin.org
Ovarian cancer has the highest mortality of all of the gynecological malignancies. There are
several distinct histotypes of this malignancy characterized by specific molecular events and …

[HTML][HTML] PTEN dual lipid-and protein-phosphatase function in tumor progression

A Liu, Y Zhu, W Chen, G Merlino, Y Yu - Cancers, 2022 - mdpi.com
Simple Summary Phosphatase and tensin homolog deleted on chromosome ten (PTEN) is a
multifunctional tumor suppressor with protein-and lipid-phosphatase activities. The …